InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Browse the complete record of transactions filed by Ajer Jeffrey Robert, Directeur et Directeur Exécutif Commercial. Officer active across 2 companies, notably NEKTAR THERAPEUTICS. In total, 11 filings have been published. Total volume traded: €358k. The latest transaction was filed on 3 June 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is openly available.
Declarations11 total
€506,0497,021 shares@ €72.07650.0044% mcap55.1% of flow
Common Stock
SEC:0001567619-22-012432:0·
€20,200340 shares@ €59.41150.0002% mcap2.2% of flow
Common Stock
SEC:0001567619-22-011966:0·
€89,3081,180 shares@ €75.68440.0008% mcap9.7% of flow
Common Stock
SEC:0001567619-22-008576:0·
€115,8701,618 shares@ €71.61330.0010% mcap12.6% of flow
Common Stock
SEC:0001567619-22-007808:0·
€152,4102,073 shares@ €73.52130.0013% mcap16.6% of flow
Common Stock
SEC:0001567619-22-007460:0·
011,940 shares0
Common Stock
SEC:0001567619-22-007177:0·
09,370 shares0
Common Stock
SEC:0001567619-22-006713:0·
€17,600342 shares@ €51.4608100.0% of flow
Common Stock
SEC:0001567619-21-018936·
€17,600342 shares@ €51.46080.0002% mcap1.9% of flow
Common Stock
SEC:0001567619-21-018936:0·
010,200 shares0
Common Stock
SEC:0001209191-21-057702·
010,200 shares0
Common Stock
SEC:0001209191-21-057702:0·
11 of 11 declarations
About Ajer Jeffrey Robert
Jeffrey Robert Ajer serves as Director and EVP, Chief Commercial Officer at Nektar Therapeutics and Biomarin Pharmaceutical Inc. He is responsible for commercial strategy and business development, contributing to the growth of both companies in the biopharmaceutical sector.
